Treatment Guidelines

Deepak Bhatt, MD: Icosapent Ethyl and REDUCE-IT Data from ESC Congress 2020

September 04, 2020

Deepak Bhatt, MD, of Brigham and Women's Hospital, offers perspective on REDUCE-IT analyses and icosapent ethyl (Vascepa) data presented at ESC Congress 2020.

Milton Packer, MD: The Evolution of the SGLT2 Inhibitor Class

September 03, 2020

Milton Packer, MD, discusses how EMPEROR-Reduced data influences the way clinicians view the SGLT2 inhibitor class and its uses.

Physician's Perspective: Role of Dietary Assessment in Cardiovascular Disease Screening

August 18, 2020

Gregory Weiss, MD, offers his perspective on a recent scientific statement from the American Heart Association underlining the importance of dietary assessments in patients seeing a cardiologist.

Marijuana and Heart Health: What We Know and The Biggest Remaining Questions

August 10, 2020

A new scientific statement from the American Heart Association is acting as a "call to action" for greater research into the effects of marijuana, according to the statement's co-author.

High-Sensitivity Troponin Testing Could Improve ASCVD Risk Stratification

August 06, 2020

Analysis of PEGASUS-TIMI 54 patients indicates incorporating the biomarker into guideline-based risk assessment could improve risk classification and care.

Meta-Analysis Compares Effects of DAPT Durations After PCI with DES

August 03, 2020

A new network meta-analysis offers an overview of the clinical benefit of less than 6 months, 6-month, 12-month, and extended periods of DAPT therapy after PCI with drug-eluting stents.

Treatment Guidelines for Managing Cholesterol Levels

April 02, 2019

In 2018, the American College of Cardiology and American Heart Association teamed up to update treatment guidelines for atherosclerotic cardiovascular disease. Learn more in this recap.

Aspirin Does Little to Prevent Cardiovascular Disease

March 26, 2019

The American College of Cardiology and the American Heart Association have updated treatment recommendations for the primary prevention of cardiovascular disease. Among the recommendations: Stop recommending aspirin to prevent CVD.